Category: Funding Roundup
Acutus Medical secured $26.2 million in new funding for its cardiac mapping technology.
Acutus Medical said it secured $26.2 million in new funding for the cardiac mapping technology it's developing to image and map atrial fibrillation hotspots.
Myoscience secures $8.4 million in new funding for its 'frotox' device that applies extreme cold to the skin to temporarily treat pain and smooth wrinkles.
Myoscience said it landed $8.4 million of a hoped-for $11.5 million for a device that applies extreme cold to the skin as a way to temporarily treat pain and smooth wrinkles.
Cohealo reports a $3.2 million debt round for the software it's developing to help hospitals manage their shared medical device inventory.
Cohealo reported raising $3.1 million of a hoped-for $5.8 million in debt financing as it develops software to help hospitals manage their shared medical device inventory.
Here's a look at some of the top legal news stories for medical device companies this week: What's behind the slump in early-stage medtech investment?; iHealth realigns, eyes the globe with new $25M investment; Ivantis adds $25M, eyes U.S. approval for glaucoma micro-stent; Minerva Surgical's just an inch away from closing a $25.5M round; Palmaz Scientific uncorks more funding
Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.
It's a hard world out there for those looking to turn their cutting edge medical device ideas into commercial products, with investors shying away from early-stage companies in favor of more established medtech enterprises.
Vital Therapies looks to raise another $46 million in a public stock offering as it works on its liver regeneration technology.
Vital Therapies (NSDQ:VTL) registered a $46 million public stock offering for its technique for the regeneration of liver tissue.
Palmaz Scientific, founded by stent pioneer Dr. Julio Palmaz, raises another $1.3 million for the prosthetic implant technology it's developing.
Palmaz Scientific recorded $1.3 million of a planned $4.2 million funding round for the prosthetic implant technology it's developing in Dallas.